The structure-activity relationship of various YO compounds, novel plasmin inhibitors, in the apoptosis induction

Biochimica et Biophysica Acta - General Subjects

Volumn 1674, Issue 3, 2004, Pages 291-298

  Enomoto, Riyo ^a   Sugahara, Chiyoko ^a   Komai, Tomoe ^a   Suzuki, Chie ^a   Kinoshita, Noriko ^a   Hosoda, Akiko ^a   Yoshikawa, Asa ^a   Tsuda, Yuko ^a   Okada, Yoshio ^a   Lee, Eibai ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Apoptosis; Plasmin inhibitor; Structure activity relationship; Thymocyte; YO compound; YO 2

Indexed keywords

4 AMINOMETHYLCYCLOHEXANECARBONYL (O PICOLYL)TYROSINE OCTYLAMIDE; AMIDE; CASPASE 3; DNA FRAGMENT; PLASMIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL SURFACE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; HYDROPHILICITY; HYDROPHOBICITY; INTRACELLULAR SPACE; MALE; MOLECULE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; THYMOCYTE;

ANIMALS; APOPTOSIS; DIPEPTIDES; DNA FRAGMENTATION; MALE; MOLECULAR CONFORMATION; PLASMIN; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 7944226842     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2004.07.004     Document Type: Article

References (12)

1. W.J. Murdoch Regulation of collagenolusis and cell death by plasmin within the formative stigma of preovulatory ovine follicles J. Reprod. Fertil. 113 1998 331 336
2. W.J. Murdoch, E.A. Van Kirk, and J. Murdoch Plasmin cleaves tumor necrosis factor α exodomain from sheep follicular endothelium: implication in the ovulatory process Biol. Reprod. 60 1999 1166 1171
3. G. Cox, W.P. Steward, and K.J. O'Byrne The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer Thorax 54 1999 169 179
4. K. Danø, P.A. Andreasen, J. Grøndahl-Hansen, P. Kristensen, L.S. Nielsen, and L. Skriver Plasminogen activators, tissue degradation, and cancer Adv. Cancer Res. 44 1985 139 266
5. B. Szende, Y. Okada, Y. Tsuda, A. Horvath, G. Bokonyi, S. Okamoto, K. Wanaka, and G. Keri A novel plasmin-inhibitor inhibits the growth of human tumor xenografts and decreases metastasis number In Vivo 16 2002 281 286
6. E. Lee, R. Enomoto, K. Takemura, Y. Tsuda, and Y. Okada A selective plasmin inhibitor, trans-aminomethylcyclohexanecarbonyl-l-(O-picolyl)tyrosine- octylamide (YO-2), induces thymocyte apoptosis Biochem. Pharmacol. 63 2002 1315 1323
7. Y. Tsuda, M. Tada, K. Wanaka, U. Okamoto, A. Hijikata-Okunomiya, S. Okamoto, and Y. Okad Structure-inhibitory activity relationship of plasmin and plasma kallikrein inhibitors Chem. Pharm. Bull. (Tokyo) 49 2001 1457 1463
8. E. Lee, M. Miura, M. Yoshinari, H. Iwai, and K. Kariya Selective inhibition of dexamethasone-induced apoptosis in rat thymocytes by herbimycin A Biochem. Biophys. Res. Commun. 202 1994 128 134
9. E. Lee, T. Furukubo, T. Miyabe, A. Yamauchi, and K. Kariya Involvement of histone hyperacetylation in triggering DNA fragmentation of rat thymocytes undergoing apoptosis FEBS Lett. 395 1996 183 187
10. G. Koopman, C.P. Reutelingsperger, G.A. Kuijten, R.M. Keehnen, S.T. Pals, and M.H. van Oers Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis Blood 84 1994 1415 1420
11. E. Lee, F. Miyaguchi, M. Inoue, K. Iya, and H. Sasaki A novel DNA cleaving agent, 2,2′-bis(2-aminoethyl)-4,4′-bithiazole, induces thymocyte apoptosis Biochem. Mol. Biol. Int. 40 1996 151 157
12. Y. Okada, Y. Tsuda, M. Tada, K. Wanaka, U. Okamoto, A. Hijikata-Okunomiya, and S. Okamoto Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationship Chem. Pharm. Bull. (Tokyo) 48 2000 1964 1972